CRP and systemic sclerosis: Patients with SSc (0.4 (0.31–0.47) mg/dL), PT (0.58 (0.41–0.65) mg/dL), and SSc + PT (0.59 (0.39–0.67) mg/dL) had increased median levels of CRP when compared to healthy controls (0.31 (0.25–0.34) mg/dL) (p < 0.001 for all evaluations) (Table 1).